1. Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin. (30th June 2015) Authors: van Hasselt, JGC; Gupta, A; Hussein, Z; Beijnen, JH; Schellens, JHM; Huitema, ADR Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 7(2015:Jul.) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity. Issue 5 (8th July 2017) Authors: Hu, S; Leblanc, AF; Gibson, AA; Hong, KW; Kim, JY; Janke, LJ; Li, L; Vasilyeva, A; Finkelstein, DB; Sprowl, JA; Sweet, DH; Schlatter, E; Ciarimboli, G; Schellens, JHM; Baker, SD; Pabla, N; Sparreboom, A Journal: Clinical and translational science Issue: Volume 10:Issue 5(2017) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration‐Resistant Prostate Cancer Treatment With Eribulin. (30th June 2015) Authors: van Hasselt, JGC; Gupta, A; Hussein, Z; Beijnen, JH; Schellens, JHM; Huitema, ADR Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 7(2015:Jul.) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacogenetics in the Cancer Clinic: From Candidate Gene Studies to Next‐Generation Sequencing. Issue 4 (21st January 2014) Authors: Guchelaar, H‐J; Gelderblom, H; van der Straaten, T; Schellens, JHM; Swen, JJ Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 4(2014) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays. (April 2014) Authors: Hendrikx, JJMA; Rosing, H; Schinkel, AH; Schellens, JHM; Beijnen, JH Journal: Bioanalysis Issue: Volume 6:Number 7(2014) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue. (November 2012) Authors: Lankheet, NAG; Schaake, EE; Rosing, H; Burgers, JA; Schellens, JHM; Beijnen, JH; Huitema, ADR Journal: Bioanalysis Issue: Volume 4:Number 21(2012) Page Start: 2563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue. (November 2012) Authors: Lankheet, NAG; Schaake, EE; Rosing, H; Burgers, JA; Schellens, JHM; Beijnen, JH; Huitema, ADR Journal: Bioanalysis Issue: Volume 4:Number 21(2012) Page Start: 2563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗